DHR vs HON: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Honeywell International Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Honeywell International Inc. · Industrials
$213.17
-9.2% upside to fair value
Grade D
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
HON trades at a lower forward P/E
(33.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
HON |
| Current Price |
$174.04 |
$213.17 |
| Fair Value Estimate |
$197.01 |
$193.51 |
| Upside to Fair Value |
+13.2%
|
-9.2%
|
| Market Cap |
$123.2B |
$135.1B |
| Forward P/E |
33.4x
|
33.0x
|
| EV / EBITDA |
20.3x
|
23.9x
|
| Price / Sales |
5.0x
|
3.7x
|
| Price / FCF |
23.3x
|
32.4x
|
| Revenue Growth YoY |
+3.7%
|
-6.9%
|
| Gross Margin |
60.7%
|
36.9%
|
| Operating Margin |
21.0%
|
14.9%
|
| Return on Equity |
7.1%
|
23.6%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
3.09%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Honeywell International Inc. is a diversified industrial conglomerate operating across Aerospace Technologies, Building Automation, Process Automation and Technology, and Safety and Productivity Solutions. The company benefits from a strong leadership team with deep internal experience and a history of strategic acquisitions that have expanded its portfolio into high-growth areas such as aerospac…
Accumulation Zones
| Metric |
DHR |
HON |
| Zone Low |
$147.76 |
$145.13 |
| Zone High |
$167.46 |
$164.48 |
| In Buy Zone? |
No
|
No
|